Novo Nordisk
NVO
NVO
639 hedge funds and large institutions have $9.9B invested in Novo Nordisk in 2019 Q4 according to their latest regulatory filings, with 118 funds opening new positions, 182 increasing their positions, 221 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
12% more capital invested
Capital invested by funds: $8.88B → $9.9B (+$1.02B)
0.16% less ownership
Funds ownership: 18.53% → 18.37% (-0.16%)
18% less repeat investments, than reductions
Existing positions increased: 182 | Existing positions reduced: 221
Holders
639
Holding in Top 10
13
Calls
$94.7M
Puts
$30M
Top Buyers
| 1 | +$82.8M | |
| 2 | +$48.1M | |
| 3 | +$42.3M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$32.3M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$26.2M |
Top Sellers
| 1 | -$201M | |
| 2 | -$67.6M | |
| 3 | -$46.5M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$36.2M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$17.4M |